PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.32B
1-Year Return
23.17%
This Quarter Return
+8.84%
1 Year Return
+23.17%
3 Year Return
+97.35%
5 Year Return
+164.6%
10 Year Return
–
AUM
$3.19B
AUM Growth
+$101M
(+3.3%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
340
New
17
Increased
56
Reduced
185
Closed
23
Top Buys
| 1 |
Snowflake
SNOW
|
$25.9M |
| 2 |
Uber
UBER
|
$18.6M |
| 3 |
Treehouse Foods
THS
|
$10.5M |
| 4 |
Golden Entertainment
GDEN
|
$9.53M |
| 5 |
DOC
PHYSICIANS REALTY TRUST
DOC
|
$9.49M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$29.4M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
$29.4M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
$14.2M |
| 4 |
Meta Platforms (Facebook)
META
|
$12.9M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$12.9M |
Sector Composition
| 1 | Technology | 20.35% |
| 2 | Healthcare | 18.05% |
| 3 | Financials | 16.4% |
| 4 | Consumer Discretionary | 13.46% |
| 5 | Industrials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
BrightView Holdings
BV
$1.37B
| $5.5M | 0.17% |
798,461
-8,659
| -1% | -$59.7K |
|
227
Openlane
KAR
$3.1B
| $5.48M | 0.17% |
419,680
-12,925
| -3% | -$169K |
|
|
CDMO
228
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $5.46M | 0.17% |
396,604
-11,666
| -3% | -$161K |
|
|
OSH
229
DELISTED
Oak Street Health, Inc.
OSH
| $5.26M | 0.16% |
244,398
-7,571
| -3% | -$163K |
|
|
VRAY
230
DELISTED
ViewRay, Inc.
VRAY
| $5.2M | 0.16% |
1,161,462
-35,284
| -3% | -$158K |
|
231
BioLife Solutions
BLFS
$1.24B
| $5.2M | 0.16% |
285,648
-8,646
| -3% | -$157K |
|
232
Monro
MNRO
$515M
| $5.08M | 0.16% |
112,405
-3,407
| -3% | -$154K |
|
233
Glaukos
GKOS
$5.17B
| $5.04M | 0.16% |
+115,452
| New | +$5.04M |
|
234
Ionis Pharmaceuticals
IONS
$9.46B
| $4.98M | 0.16% |
131,711
+8,315
| +7% | +$314K |
|
235
PAR Technology
PAR
$1.95B
| $4.82M | 0.15% |
185,017
-5,602
| -3% | -$146K |
|
|
ZUO
236
DELISTED
Zuora, Inc.
ZUO
| $4.5M | 0.14% |
707,656
-21,176
| -3% | -$135K |
|
237
FormFactor
FORM
$2.23B
| $4.36M | 0.14% |
196,037
-5,513
| -3% | -$123K |
|
238
Clarivate
CLVT
$2.86B
| $4.32M | 0.14% |
518,063
+40,500
| +8% | +$338K |
|
|
SWTX
239
DELISTED
SpringWorks Therapeutics
SWTX
| $4.28M | 0.13% |
+164,541
| New | +$4.28M |
|
240
NovoCure
NVCR
$1.34B
| $2.41M | 0.08% |
32,912
-7,918
| -19% | -$581K |
|
241
Adaptive Biotechnologies
ADPT
$1.98B
| $2.05M | 0.06% |
267,631
-11,100
| -4% | -$84.8K |
|
242
Iovance Biotherapeutics
IOVA
$796M
| $1.87M | 0.06% |
292,165
+50,671
| +21% | +$324K |
|
243
Danaher
DHR
$143B
| $1.61M | 0.05% |
6,838
| – | – |
|
244
Manhattan Associates
MANH
$12.7B
| $1.58M | 0.05% |
13,007
| – | – |
|
245
Bunge Global
BG
$16.2B
| $1.57M | 0.05% |
15,707
| – | – |
|
246
Cognex
CGNX
$7.43B
| $1.44M | 0.05% |
30,636
| – | – |
|
247
WESCO International
WCC
$10.6B
| $1.42M | 0.04% |
11,355
| – | – |
|
248
Canadian Pacific Kansas City
CP
$70.5B
| $1.39M | 0.04% |
18,581
| – | – |
|
249
Novanta
NOVT
$4.15B
| $1.38M | 0.04% |
10,181
| – | – |
|
250
First Solar
FSLR
$21.7B
| $1.35M | 0.04% |
9,037
+2,600
| +40% | +$390K |
|